[Event Report] The 3rd AMR Global Expert Meeting “Side Event at the Tokyo AMR One-Health Conference” -Measures Should Be Taken to Achieve Action Plan- (14 November 2017)

date : 11/15/2017

Tags: AMR

The 3rd AMR Global Expert Meeting “Side Event at the Tokyo AMR One-Health Conference” -Measures Should Be Taken to Achieve Action Plan- was convened by Health and Global Policy Institute (HGPI) on Tuesday, 14 November 2017.

On April 18, 2016, the Center for Strategic and International Studies (CSIS) and HGPI jointly convened the U.S.-Japan expert meeting on Antimicrobial resistance (AMR). Amidst the momentum following the Tokyo Meeting of Health Ministers on Antimicrobial Resistance in Asia, this meeting provided a platform for open and active policy discussions. Active discussions involved multiple stakeholders from public, private, and civil society. Subsequently, on July 21, 2017, the 2nd AMR Global Expert Meeting entitled “Post G7 Ise-Shima Summit: Reflecting upon Japan’s National Action Plan and Addressing Next Steps for Global Antimicrobial Resistance” was convened to further encourage measures to address AMR. Issues included future challenges of the global action plan for AMR, and industry-government-academia cooperation. The policies Japan needs to adopt in the future were discussed by more than 100 guests in attendance. Guests were both domestic and international, including public and private health experts, ministry officials, academia, and civil society.

On November 14, 2017, the 3rd AMR Global Expert Meeting was organized. The forum was intended to focus on methods to deliver incentives for the development of new antibacterial drugs, as well as the promotion of speedy and accurate diagnostic methods and global contribution from Japan. In order to continue the momentum and promote the development of more specific policy issues, this meeting was aligned with the “Tokyo AMR One-Health Conference”, which was held by the MHLW of Japan on November 13 and 14, 2017.

The expert meeting featured multi-stakeholder discussions on solutions for AMR, for which prompt research and development is needed, which involved healthcare experts, private sector officials, academics, ministry officials and civic representatives in the relevant area, both in Japan and abroad.

Welcoming Remarks

Kiyoshi Kurokawa (Chairman, HGPI)

Opening Address

Chieko Ikeda (Senior Assistant Minister for Global Health, MHLW)

Panel Discussion

Panelists:

Chifumi Umeda (Executive Officer, Head of Acute Care Hospital Business Unit/ Head of Vaccines Business Unit, MSD K.K.)

Mitsuo Kaku (Professor, Infection Control and Laboratory Diagnostics, Internal Medicine, Department of Medical Sciences, Graduate School of Medicine, Tohoku University)